Minocycline Hydrochloride Oral Tablet, Extended Release 135Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Minocycline Hydrochloride: Oral tablet, extended release (135mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Minocycline 135mg ER Tab
Drug Image file default-drug-image.png
Minocycline 135mg ER Tab
Drug Image file default-drug-image.png
Minocycline 135mg ER Tab

What is this Medicine?

MINOCYCLINE (mi noe SYE kleen) is a tetracycline antibiotic. It is used to treat certain kinds of bacterial infections. It will not work for colds, flu, or other viral infections.

CVS Pharmacy Patient Statistics for Minocycline Hydrochloride: Oral tablet, extended release(135mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Minocycline Hydrochloride 135mg Extended-Release Tablet

NDC: 007815387
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Pneumonia, Yaws, Anthrax, Chancroid, Urethritis, Chlamydial Conjunctivitis, Upper Respiratory Tract Infections, Non-gonococcal Urethritis (NGU), Rickettsial Pox, Syphilis, Chlamydia Infection, Actinomycosis, Q Fever, Cellulitis, Psittacosis, Listeriosis, Skin And Skin Structure Infections, Mycobacterium Marinum Infection, Lymphogranuloma Venereum, Campylobacter Fetus Infections, Meningococcal Infection Prophylaxis, Bartonellosis, Cholera, Murine Typhus, Rocky Mountain Spotted Fever, Brucellosis, Periodontitis, Necrotizing Ulcerative Gingivitis, Relapsing Fever, Bronchitis, Granuloma Inguinale, Cervicitis, Gonorrhea, Acne Vulgaris, Proctitis, Tularemia, Amebiasis, Urinary Tract Infection (UTI), Lower Respiratory Tract Infections, Plague

Sometimes used for but not FDA approved for the following conditions:
Dental Infection, Endodontic Infection, Dentoalveolar Infection, Prostatitis, Pemphigus, Rheumatoid Arthritis

Storage Information
Protect from light
Protect from moisture
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Avoid excessive heat (above 104 degrees F)
Minocycline Hydrochloride 135mg Extended-Release Tablet

Reported Side Effects for Minocycline Hydrochloride 135mg Extended-Release Tablet

Joint Pain Incidence:
1.0%*
Severity: MILD
Onset: DELAYED
Dry Mouth Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Balance Problems Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Hives Incidence:
2.0%*
Severity: MILD
Onset: RAPID
Drowsiness Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Feeling Sick Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
5.0%*
Severity: MILD
Onset: RAPID
Mouth Ulcers Incidence:
6.4%*
Severity: MODERATE
Onset: DELAYED
Tired Incidence:
9.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
9.0-23.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
9.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
30.0-40.0%*
Severity: MILD
Onset: EARLY
Decreased Appetite Incidence:
30.0-40.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
30.0-40.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Minocycline Hydrochloride

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.